Roche still confident on Ventana buyout

Does he know something we don't? Roche CEO Franz Humer says he's "very confident" that the company's $3 billion takeover bid for Ventana will be accepted.

Humer also told the Financial Times today that hedge funds have bought out Ventana's leading shareholders. And he has "no intention" of increasing the value of Roche's tender offer, despite the fact that the $75 buyout price is less than Ventana's current stock price.

- read the Financial Times article

Read more on: Roche

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.